Based on our results, one possibility may be that the expression levels of TM4SF1-interacted integrins and the membrane receptors that TM4SF1 interacted with are variable in a cancer or ESCC cell type-dependent manner, thus mediating different downstream signal pathways, which need further investigation. This evidence concerns the gene TM4SF1 and cancer.